EF Hutton analyst Michael King reiterates Ocean Biomedical (NASDAQ:OCEA) with a Buy and maintains $10 price target.
EF Hutton Reiterates Buy on Ocean Biomedical, Maintains $10 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.